MAPT and neurodegenerative disease: If a control cohort not separated by age is used, most healthy individuals should show high values at ages older than 55, and this would make the study of neurodegenerative diseases such as Alzheimer’s, where high sGFAP values have proven to be essential for the formation of Tau tangles, difficult [21].